Antidoping Lab Qatar (ADLQ)

Site

Doping Analysis Lab ADLQ

Accreditation No.

19306

Site No.

22003

Date of Accreditation

24 Dec 2013

Address

Sports City Road, Aspire Zone, PO Box 27775, DOHA
0
Qatar

adlqatar.net

Contact

Dr Alka Beotra P: 97 444132915

Availability

Services not available to external clients

Scope of Accreditation

Doping Analysis Lab ADLQ

ISO/IEC 17025 (2017)

Legal - Analysis for compliance with WADA and sporting federation requirements

Service Product Determinant Technique Procedure
Analysis for sports drugs and drug metabolites Human blood M1: Manipulation of blood and blood components (blood analysis for the haematological model for athlete biological passport); S2: Peptide hormones, growth factors, related substances, and mimetics Electrical impedance; Flow cytometry; Lysation; Sysmex XN 1000

in-house method SOP 109:ITP, CP

Human growth hormone (HGH); S2: Peptide hormones, growth factors, related substances, and mimetics (human growth hormone - isoform) Affinity-binding assay

in-house method SOP 107:ITP, CP

Human blood; Human urine Benzodiazepines; Erythropoietin (EPO) stimulating agents; S2: Peptide hormones, growth factors, related substances, and mimetics (erythropoiesis stimulating agents - SAR-PAGE, IEF-PAGE) Gel electrophoresis; Immunoblot; Immunopurification

in-house method SOP 104

Human urine Formoterol; S3: Beta-2 agonists Enzymatic hydrolysis; LC-MSn (n?1)

in-house method SOP 124:CP

S1: Anabolic agents Derivatization; GC-MSn (n?1); Gas chromatography - Combustion - Isotope ratio mass spectrometry (GC-C-IRMS); Liquid chromatography (LC); Liquid liquid extraction; Solid phase extraction

in-house method SOP 105:CP

Plasma volume expanders; S5: Diuretics and masking agents GC-MSn (n?1); LC-MSn (n?1)

in-house method SOP 106:ITP, CP

19-Norandrosterone (19-NA); S1: Anabolic agents Derivatization; Enzymatic hydrolysis; GC-MSn (n?1); Liquid liquid extraction

in-house method SOP 119:CP

S2: Peptide hormones, growth factors, related substances, and mimetics (chorionic gonadotrophin and luteinizing hormone) Affinity-binding assay

in-house method SOP 103:ITP, CP

Blood parameters; S1: Anabolic agents (including steroid profiling) Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-MSn (n?1); LC-MSn (n?1); Liquid liquid extraction; Solid phase extraction

in-house method SOP 125:CP

Ethylglucuronide (ETG) Dilute and shoot; LC-MSn (n?1) in-house method SOP 113
Morphine; S7: Narcotics Enzymatic hydrolysis; LC-MSn (n?1)

in-house method SOP 122:CP

11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; S8: Cannabinoids Enzymatic hydrolysis; LC-MSn (n?1)

in-house method SOP 121:CP

M1: Manipulation of blood and blood components; P1: Beta-blockers; S1: Anabolic agents; S2: Peptide hormones, growth factors, related substances, and mimetics (chorionic gonadotrophin and luteinizing hormone); S3: Beta-2 agonists; S4: Hormone and metabolic modulators; S5: Diuretics and masking agents; S6: Stimulants; S7: Narcotics; S8: Cannabinoids; S9: Glucocorticoids Derivatization; Enzymatic hydrolysis; GC-MSn (n?1); LC-MSn (n?1); Liquid liquid extraction

in-house method SOP 102: ITP, CP

S3: Beta-2 agonists; Salbutamol Enzymatic hydrolysis; LC-MSn (n?1)

in-house method SOP 123:CP

Ephedrine; S6: Stimulants Dilute and shoot; LC-HRMSn (n?1)

in-house method SOP 120:CP

pH Potentiometric

in-house method SOP 015

Specific gravity Refractometry

in-house method SOP 009

Luteinising hormone (LH); S2: Peptide hormones, growth factors, related substances, and mimetics Affinity-binding assay

in-house method SOP 118: ITP, CP

S2: Peptide hormones, growth factors, related substances, and mimetics; Small peptides LC-MSn (n?1); Solid phase extraction

in-house method SOP 115:ITP, CP

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Monitoring of animals for drugs, metabolites and other substances - Quantitative analysis Equine plasma Carbon dioxide - Total; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules
Equine plasma; Equine urine Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules; Salicylic acid; Theobromine
Dimethylsulfoxide; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules
Agonists; Anabolic agents; Anti-inflammatories; Antidepressants; Corticosteroids; Diuretics; Masking agents; Metabolic modulators; Muscle relaxants; Narcotics; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules; Sedatives; Stimulants; β-Blockers
Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules; Testosterone
Equine urine Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules; Small peptides
3-Methoxytyramine; Cortisol; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules
Boldenone; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules
Arsenic; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.